Ascendis Pharma A/S (ASND) stock analysis

In our weekly check, Ascendis Pharma A/S is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 14 pass, warnings: 4, red flags: 5.

Sector: Healthcare · Biotechnology

Strengths

• Low debt
• Margins rising
• High margins

Warning signs

• Weak interest cover
• Profits not backed by cash
• Heavy stock pay
• Weak free cash flow
• Very volatile

Next earnings report: 2026-11-11

Similar companies

SMMT · JAZZ · EXEL · HALO · BBIO · TECH

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-10

Open the full analysis